National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

indium I 111 chimeric monoclonal antibody G250
A radioimmunoconjugate comprised of the chimeric monoclonal antibody G250 conjugated with the gamma-emitting radioisotope indium In 111. Indium I 111 chimeric monoclonal antibody G250 binds to G250, allowing the localization of G250-expressing tumor cells using gamma scintigraphy. Found in the majority of renal cell carcinomas (RCCs), G250 or carbonic anhydrase isozyme IX (CA IX) is a cell surface tumor-associated antigen (TAA). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:111-indium labeled chimeric monoclonal antibody G250



Previous:incyclinide, indibulin, indicine-N-oxide, indinavir sulfate, indium I 111 bevacizumab
Next:indium In 111 chimeric monoclonal antibody 806, indium In 111 CHX-A DTPA trastuzumab, indium In 111 ibritumomab tiuxetan, indium In 111 monoclonal antibody BrE-3, indium In 111 monoclonal antibody huPAM4

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov